HEADER TRANSFERASE 16-DEC-03 1UU9 TITLE STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 22-307; COMPND 5 SYNONYM: HPDK1; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SPODOPTERA FRUGIPERDA; SOURCE 3 ORGANISM_COMMON: FALL ARMYWORM; SOURCE 4 ORGANISM_TAXID: 7108; SOURCE 5 CELL_LINE: SF21; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1; SOURCE 11 OTHER_DETAILS: BACULOVIRUS INFECTED KEYWDS PROTEIN KINASE, PKB, PDK1, INHIBITOR, LY333531, BISINDOLYL MALEIMIDE, KEYWDS 2 BIM-1, DIABETES, CANCER, TRANSFERASE, SERINE/THREONINE-PROTEIN KEYWDS 3 KINASE EXPDTA X-RAY DIFFRACTION AUTHOR D.KOMANDER,G.S.KULAR,A.W.SCHUTTELKOPF,M.DEAK,K.R.PRAKASH,J.BAIN, AUTHOR 2 M.ELLIOT,M.GARRIDO-FRANCO,A.P.KOZIKOWSKI,D.R.ALESSI,D.M.F.VAN AALTEN REVDAT 5 23-OCT-24 1UU9 1 REMARK REVDAT 4 13-DEC-23 1UU9 1 REMARK REVDAT 3 24-APR-19 1UU9 1 SOURCE REMARK LINK REVDAT 2 24-FEB-09 1UU9 1 VERSN REVDAT 1 04-MAR-04 1UU9 0 JRNL AUTH D.KOMANDER,G.S.KULAR,A.W.SCHUTTELKOPF,M.DEAK,K.R.PRAKASH, JRNL AUTH 2 J.BAIN,M.ELLIOT,M.GARRIDO-FRANCO,A.P.KOZIKOWSKI,D.R.ALESSI, JRNL AUTH 3 D.M.F.VAN AALTEN JRNL TITL INTERACTIONS OF LY333531 AND OTHER BISINDOLYL MALEIMIDE JRNL TITL 2 INHIBITORS WITH PDK1 JRNL REF STRUCTURE V. 12 215 2004 JRNL REFN ISSN 0969-2126 JRNL PMID 14962382 JRNL DOI 10.1016/J.STR.2004.01.005 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 29902 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.100 REMARK 3 FREE R VALUE TEST SET COUNT : 623 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2229 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 227 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.05000 REMARK 3 B22 (A**2) : 2.05000 REMARK 3 B33 (A**2) : -4.10000 REMARK 3 B12 (A**2) : 0.96000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.159 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.152 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.122 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.062 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SOME SIDECHAINS REFINED WITH ZERO REMARK 3 OCCUPANCY DUE TO DISORDER. REMARK 4 REMARK 4 1UU9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1290014213. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29917 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.58600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1H1W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 M AMMONIUM SULPHATE, 0.1 M TRIS REMARK 280 -HCL PH 8.25, PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.01200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 16.00600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 16.00600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.01200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2073 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2170 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 231 REMARK 465 PRO A 232 REMARK 465 GLU A 233 REMARK 465 SER A 234 REMARK 465 LYS A 235 REMARK 465 GLN A 236 REMARK 465 ALA A 237 REMARK 465 ARG A 238 REMARK 465 ALA A 239 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 73 CG CD OE1 NE2 REMARK 470 ARG A 116 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 120 CG CD CE NZ REMARK 470 GLU A 215 CG CD OE1 OE2 REMARK 470 LYS A 228 CG CD CE NZ REMARK 470 LYS A 257 CG CD CE NZ REMARK 470 LYS A 304 CG CD CE NZ REMARK 470 GLU A 328 CG CD OE1 OE2 REMARK 470 GLU A 348 CG CD OE1 OE2 REMARK 470 LYS A 357 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 78 NE CZ NH1 NH2 REMARK 480 LYS A 83 NZ REMARK 480 LYS A 173 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2152 O HOH A 2197 2.12 REMARK 500 SG CYS A 327 O HOH A 2152 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 138 74.12 -151.09 REMARK 500 ASP A 151 -163.43 -118.91 REMARK 500 ARG A 204 -6.60 77.02 REMARK 500 ASP A 205 46.43 -145.42 REMARK 500 ASP A 223 72.55 68.82 REMARK 500 ASN A 349 42.33 -142.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1365 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1366 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1367 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1368 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1369 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BI3 A1370 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1357 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1358 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1359 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1360 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1361 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1362 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1363 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1364 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H1W RELATED DB: PDB REMARK 900 HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN REMARK 900 RELATED ID: 1OKY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE REMARK 900 RELATED ID: 1OKZ RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01 REMARK 900 RELATED ID: 1UU3 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531 REMARK 900 RELATED ID: 1UU7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2 REMARK 900 RELATED ID: 1UU8 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1 REMARK 900 RELATED ID: 1UVR RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8 DBREF 1UU9 A 72 357 UNP O15530 PDPK_HUMAN 22 307 SEQRES 1 A 286 PRO GLN PRO ARG LYS LYS ARG PRO GLU ASP PHE LYS PHE SEQRES 2 A 286 GLY LYS ILE LEU GLY GLU GLY SER PHE SER THR VAL VAL SEQRES 3 A 286 LEU ALA ARG GLU LEU ALA THR SER ARG GLU TYR ALA ILE SEQRES 4 A 286 LYS ILE LEU GLU LYS ARG HIS ILE ILE LYS GLU ASN LYS SEQRES 5 A 286 VAL PRO TYR VAL THR ARG GLU ARG ASP VAL MET SER ARG SEQRES 6 A 286 LEU ASP HIS PRO PHE PHE VAL LYS LEU TYR PHE THR PHE SEQRES 7 A 286 GLN ASP ASP GLU LYS LEU TYR PHE GLY LEU SER TYR ALA SEQRES 8 A 286 LYS ASN GLY GLU LEU LEU LYS TYR ILE ARG LYS ILE GLY SEQRES 9 A 286 SER PHE ASP GLU THR CYS THR ARG PHE TYR THR ALA GLU SEQRES 10 A 286 ILE VAL SER ALA LEU GLU TYR LEU HIS GLY LYS GLY ILE SEQRES 11 A 286 ILE HIS ARG ASP LEU LYS PRO GLU ASN ILE LEU LEU ASN SEQRES 12 A 286 GLU ASP MET HIS ILE GLN ILE THR ASP PHE GLY THR ALA SEQRES 13 A 286 LYS VAL LEU SER PRO GLU SER LYS GLN ALA ARG ALA ASN SEQRES 14 A 286 SEP PHE VAL GLY THR ALA GLN TYR VAL SER PRO GLU LEU SEQRES 15 A 286 LEU THR GLU LYS SER ALA CYS LYS SER SER ASP LEU TRP SEQRES 16 A 286 ALA LEU GLY CYS ILE ILE TYR GLN LEU VAL ALA GLY LEU SEQRES 17 A 286 PRO PRO PHE ARG ALA GLY ASN GLU TYR LEU ILE PHE GLN SEQRES 18 A 286 LYS ILE ILE LYS LEU GLU TYR ASP PHE PRO GLU LYS PHE SEQRES 19 A 286 PHE PRO LYS ALA ARG ASP LEU VAL GLU LYS LEU LEU VAL SEQRES 20 A 286 LEU ASP ALA THR LYS ARG LEU GLY CYS GLU GLU MET GLU SEQRES 21 A 286 GLY TYR GLY PRO LEU LYS ALA HIS PRO PHE PHE GLU SER SEQRES 22 A 286 VAL THR TRP GLU ASN LEU HIS GLN GLN THR PRO PRO LYS MODRES 1UU9 SEP A 241 SER PHOSPHOSERINE HET SEP A 241 10 HET GOL A1357 6 HET GOL A1358 6 HET GOL A1359 6 HET GOL A1360 6 HET GOL A1361 6 HET GOL A1362 6 HET GOL A1363 6 HET GOL A1364 6 HET SO4 A1365 5 HET SO4 A1366 5 HET SO4 A1367 5 HET SO4 A1368 5 HET SO4 A1369 5 HET BI3 A1370 29 HETNAM SEP PHOSPHOSERINE HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM BI3 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)- HETNAM 2 BI3 1H-PYRROLE-2,5-DIONE HETSYN SEP PHOSPHONOSERINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN BI3 INHIBITOR OF 3-PHOSPHOINOSITIDE DEPENDENT PROTEIN HETSYN 2 BI3 KINASE-1 FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 GOL 8(C3 H8 O3) FORMUL 10 SO4 5(O4 S 2-) FORMUL 15 BI3 C23 H20 N4 O2 FORMUL 16 HOH *227(H2 O) HELIX 1 1 ARG A 78 GLU A 80 5 3 HELIX 2 2 LYS A 115 GLU A 121 1 7 HELIX 3 3 LYS A 123 LEU A 137 1 15 HELIX 4 4 GLU A 166 GLY A 175 1 10 HELIX 5 5 ASP A 178 LYS A 199 1 22 HELIX 6 6 LYS A 207 GLU A 209 5 3 HELIX 7 7 THR A 245 VAL A 249 5 5 HELIX 8 8 SER A 250 GLU A 256 1 7 HELIX 9 9 CYS A 260 GLY A 278 1 19 HELIX 10 10 ASN A 286 LYS A 296 1 11 HELIX 11 11 PHE A 306 LEU A 317 1 12 HELIX 12 12 ASP A 320 ARG A 324 5 5 HELIX 13 13 CYS A 327 GLU A 331 5 5 HELIX 14 14 GLY A 332 ALA A 338 1 7 HELIX 15 15 HIS A 339 GLU A 343 5 5 HELIX 16 16 THR A 346 GLN A 353 5 8 SHEET 1 AA 5 PHE A 82 GLU A 90 0 SHEET 2 AA 5 SER A 94 GLU A 101 -1 O VAL A 96 N LEU A 88 SHEET 3 AA 5 GLU A 107 GLU A 114 -1 O TYR A 108 N ALA A 99 SHEET 4 AA 5 LYS A 154 LEU A 159 -1 O LEU A 155 N LEU A 113 SHEET 5 AA 5 LEU A 145 GLN A 150 -1 N TYR A 146 O GLY A 158 SHEET 1 AB 2 ILE A 201 ILE A 202 0 SHEET 2 AB 2 LYS A 228 VAL A 229 -1 O LYS A 228 N ILE A 202 SHEET 1 AC 2 ILE A 211 LEU A 213 0 SHEET 2 AC 2 ILE A 219 ILE A 221 -1 O GLN A 220 N LEU A 212 LINK C ASN A 240 N SEP A 241 1555 1555 1.33 LINK C SEP A 241 N PHE A 242 1555 1555 1.33 SITE 1 AC1 5 LYS A 76 ARG A 131 THR A 148 GLN A 150 SITE 2 AC1 5 HOH A2058 SITE 1 AC2 7 LYS A 144 TYR A 146 SER A 160 GLN A 220 SITE 2 AC2 7 GOL A1364 HOH A2132 HOH A2225 SITE 1 AC3 5 ARG A 106 LYS A 144 HIS A 351 GOL A1364 SITE 2 AC3 5 HOH A2226 SITE 1 AC4 7 GLY A 91 SER A 92 PHE A 93 SER A 94 SITE 2 AC4 7 GOL A1358 GOL A1363 HOH A2227 SITE 1 AC5 3 ARG A 75 ARG A 136 LYS A 199 SITE 1 AC6 17 LEU A 88 GLY A 89 ALA A 109 LYS A 111 SITE 2 AC6 17 VAL A 143 LEU A 159 SER A 160 TYR A 161 SITE 3 AC6 17 ALA A 162 GLU A 166 GLU A 209 ASN A 210 SITE 4 AC6 17 LEU A 212 THR A 222 ASP A 223 GOL A1363 SITE 5 AC6 17 HOH A2223 SITE 1 AC7 10 ALA A 103 THR A 104 SER A 105 HIS A 139 SITE 2 AC7 10 SER A 191 TRP A 347 GLU A 348 ASN A 349 SITE 3 AC7 10 LEU A 350 HIS A 351 SITE 1 AC8 7 LYS A 111 LEU A 113 TYR A 126 GLU A 130 SITE 2 AC8 7 GLY A 225 GOL A1363 SO4 A1368 SITE 1 AC9 5 PRO A 79 LYS A 154 TYR A 156 GLU A 331 SITE 2 AC9 5 GLY A 332 SITE 1 BC1 5 LYS A 83 VAL A 345 THR A 346 TRP A 347 SITE 2 BC1 5 GLU A 348 SITE 1 BC2 3 LEU A 297 TYR A 299 PHE A 301 SITE 1 BC3 8 PHE A 82 LYS A 83 PHE A 84 GLU A 194 SITE 2 BC3 8 GLY A 334 LYS A 337 HOH A2221 HOH A2222 SITE 1 BC4 9 GLY A 91 SER A 94 VAL A 96 LYS A 111 SITE 2 BC4 9 GOL A1358 SO4 A1368 BI3 A1370 HOH A2223 SITE 3 BC4 9 HOH A2227 SITE 1 BC5 8 ARG A 106 GLU A 107 SER A 160 TYR A 161 SITE 2 BC5 8 SO4 A1366 SO4 A1367 HOH A2083 HOH A2224 CRYST1 121.629 121.629 48.018 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008222 0.004747 0.000000 0.00000 SCALE2 0.000000 0.009494 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020825 0.00000